Sonia Fox

414 total citations
11 papers, 41 citations indexed

About

Sonia Fox is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Sonia Fox has authored 11 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Sonia Fox's work include Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sonia Fox is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Sonia Fox collaborates with scholars based in United Kingdom, United States and India. Sonia Fox's co-authors include Aimee Jackson, Rebecca H. Boucher, Toby A. Eyre, Anna Schuh, Francesca Yates, Maité Cabes, Peter Hillmen, Andy C. Rawstron, Niamh Appleby and Keith Wheatley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Sonia Fox

11 papers receiving 41 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonia Fox United Kingdom	4	22	20	20	13	11	11	41
Thomas Cummin United Kingdom	4	32 1.5×	9 0.5×	16 0.8×	13 1.0×	18 1.6×	6	46
Shaneice Mitchell United States	4	22 1.0×	17 0.8×	12 0.6×	27 2.1×	8 0.7×	8	47
Neus Ruiz‐Xivillé Spain	6	10 0.5×	15 0.8×	16 0.8×	15 1.2×	8 0.7×	8	34
Phillip Michaels United States	4	10 0.5×	13 0.7×	28 1.4×	19 1.5×	10 0.9×	12	63
Katya Ahr United States	3	18 0.8×	16 0.8×	29 1.4×	6 0.5×	20 1.8×	4	45
Nicole Lucas United States	2	9 0.4×	18 0.9×	21 1.1×	5 0.4×	9 0.8×	6	28
Sophia Sohoni United States	2	7 0.3×	27 1.4×	23 1.1×	9 0.7×	13 1.2×	3	35
Anna Alperovich United States	4	7 0.3×	16 0.8×	27 1.4×	8 0.6×	19 1.7×	10	42
Aránzazu García‐Mateo Spain	3	21 1.0×	19 0.9×	16 0.8×	13 1.0×	5 0.5×	4	38
Adriana Perilla-Glen United States	3	7 0.3×	24 1.2×	23 1.1×	10 0.8×	6 0.5×	4	33

Countries citing papers authored by Sonia Fox

Since Specialization

Citations

This map shows the geographic impact of Sonia Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Fox more than expected).

Fields of papers citing papers by Sonia Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Fox. The network helps show where Sonia Fox may publish in the future.

Co-authorship network of co-authors of Sonia Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Fox. A scholar is included among the top collaborators of Sonia Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Fox. Sonia Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

McIlroy, Graham, Charlotte Gaskell, Aimee Jackson, et al.. (2025). Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial. BMC Cancer. 25(1). 56–56. 1 indexed citations

McIlroy, Graham, Siân Lax, Charlotte Gaskell, et al.. (2024). Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial. BMC Cancer. 24(1). 370–370. 1 indexed citations

Harrison, Claire, Sonia Fox, Rebecca H. Boucher, Mary Frances McMullin, & Adam J. Mead. (2024). Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary. Future Oncology. 20(40). 3365–3376. 1 indexed citations

Hamblin, Angela, Sonia Fox, Christina Yap, et al.. (2023). The SF3B1 K666 Hotspot Mutation Confers Unfavourable Disease Risk across Major Myeloid Neoplasm Subgroups. Blood. 142(Supplement 1). 4552–4552. 1 indexed citations

Dillon, Richard, Aimee Jackson, Sonia Fox, et al.. (2022). Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial. BMC Cancer. 22(1). 1174–1174. 2 indexed citations

Metzner, Marlen, Batchimeg Usukhbayar, Aimee Jackson, et al.. (2022). Heterogeneous genetic and non‐genetic mechanisms contribute to response and resistance to azacitidine monotherapy. SHILAP Revista de lepidopterología. 3(3). 794–803. 2 indexed citations

Loke, Justin, Marlen Metzner, Rebecca H. Boucher, et al.. (2021). Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology. 196(2). 368–373. 3 indexed citations

Appleby, Niamh, Toby A. Eyre, Maité Cabes, et al.. (2019). The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer. 19(1). 471–471. 19 indexed citations

Murray, J. A. H., Guy Pratt, Fiona Clark, et al.. (2019). Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers. Contemporary Clinical Trials Communications. 14. 100361–100361. 7 indexed citations

10.

Craddock, Charles, Aimee E. Houlton, Paul Ferguson, et al.. (2016). Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial. Blood. 128(22). 1065–1065. 3 indexed citations

11.

Scherber, Robyn M., Steven Knapper, Sonia Fox, et al.. (2015). Assessment and Validation of the EQ-5D Among a Population of Myeloproliferative Neoplasm Patients. Blood. 126(23). 5179–5179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact